Advertisement

Topics

Catalent, Inc. to Present at the Raymond James 38th Annual Institutional Investors Conference

16:15 EST 22 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Matthew Walsh, Executive Vice President...

Other Sources for this Article

Catalent, Inc.
Thomas Castellano, 732-537-6325
investors@catalent.com

NEXT ARTICLE

More From BioPortfolio on "Catalent, Inc. to Present at the Raymond James 38th Annual Institutional Investors Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...